Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cleveland Clinic journal of medicine

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3949/ccjm.80a.13077PMID 24001961PMCID PMC3906667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of azithromycin and death from cardiovascular causes.

  2013cited by this paper
• Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database

  2013cited by this paper
• Cardiovascular risks with azithromycin and other antibacterial drugs.

  2013cited by this paper
• Institution-wide QT alert system identifies patients with a high risk of mortality.

  2013cited by this paper
• Azithromycin and the risk of cardiovascular death.

  2012cited by this paper
• Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

  2010cited by this paper
• Quantitative signal detection using spontaneous ADR reporting

  2009cited by this paper
• Data mining for signals in spontaneous reporting databases: proceed with caution

  2007cited by this paper
• Antimicrobial-associated QT interval prolongation: pointes of interest.

  2006cited by this paper
• Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System.

  2002cited by this paper
• Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes

  2002cited by this paper
• [Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome].

  2001cited by this paper
• Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections.

  2001cited by this paper
• Clinical toleration and safety of azithromycin.

  1991cited by this paper

• Influential predictors of azithromycin pharmacokinetics: a systematic review of population pharmacokinetics

  2025cites this paper
• Systematic development and optimization of a microfluidic formulation protocol for liposomal azithromycin

  2025cites this paper
• Synergistic Cardiotoxic Effects of Captagon and Azithromycin in Rat via Oxidative stress, Apoptosis and Upregulation of the PI3K/AKT/NF-kB pathway.

  2025cites this paper
• A novel mutation in hERG gene associated with azithromycin-induced acquired long QT syndrome

  2024cites this paper
• Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells: Implication of a Potential Drug-ADC Interaction in Cancer Chemotherapy.

  2023cites this paper
• Importance of Magnesium Status in COVID-19

  2023cites this paper
• Delivering macrolide antibiotics to heal a broken heart - and other inflammatory conditions.

  2022cites this paper
• Optimization and Characterization of a Liposomal Azithromycin Formulation for Alternative Macrophage Activation

  2022cites this paper
• Use of Azithromycin in Pregnancy: More Doubts than Certainties

  2022cites this paper
• Two years later, azithromycin for COVID-19 and the effect on the heart, is it still relevant?

  2022cites this paper
• Potential Drug–Drug Interactions among Hospitalized COVID-19 Patients Admitted to Medical Wards of a Referral Hospital, North-East of Iran: A Cross Sectional Study

  2021cites this paper
• A review of cardiovascular involvements associated with medications used to treat COVID-19 infection

  2021cites this paper
• Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations

  2021cites this paper
• Ameliorative potential of phytochemicals against side effects of COVID-19 drugs: A review

  2021cites this paper
• Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: A European case-control study.

  2021cites this paper
• Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study

  2021cites this paper
• Lactoferrin Ameliorates Azithromycin-induced Cardiac Injury: Insight into Oxidative Stress/TLR4 /NF-κB Pathway

  2021cites this paper
• Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19

  2021cites this paper
• Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity

  2021cites this paper
• Drugs Resistance in Lungs Diseases

  2021cites this paper
• COVID-19 Pandemic Impact on Physicians’ Decision-making: Digoxin Toxicity in View of Combination of Hydroxychloroquine and Azithromycin: A Case Report

  2020cites this paper
• COVID-19: Chloroquine and hydroxychloroquine research

  2020cites this paper
• Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

  2020cites this paper
• COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine

  2020cites this paper
• Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans

  2020cites this paper
• Comparative Study of the Effect of Macrolide Antibiotics Erythromycin, Clarithromycin, and Azithromycin on the ERG1 Gene Expression in H9c2 Cardiomyoblast Cells

  2020cites this paper
• Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction

  2020cites this paper
• Coronavirus Disease: New Humans Challenge and Known Approaches to Treatment

  2020cites this paper
• Severe Cardiovascular Complications of COVID-19: a Challenge for the Physician

  2020cites this paper
• Cardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias

  2018cites this paper
• An eye for azithromycin: review of the literature

  2018cites this paper
• Does macrolide use confer risk of out-of-hospital cardiac arrest compared with penicillin V? A Danish national case-crossover and case–time–control study

  2018cites this paper
• Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review

  2017influential citation
• Incidence of Sustained Ventricular Tachycardia in Patients with Prolonged QTc After the Administration of Azithromycin: A Retrospective Study

  2016cites this paper
• Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial

  2016cites this paper
• Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.

  2015cites this paper
• The place of azithromycin in the treatment of periodontal disease

  2015cites this paper
• [Prevalence of potential drug interactions with azithromycin in Colombia, 2012-2013].

  2015cites this paper
• Evaluation of azithromycin induced cardiotoxicity in rats.

  2015cites this paper
• Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update.

  2015cites this paper
• Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity

  2014cites this paper
• Pharmacokinetics, Microbial Response, and Pulmonary Outcomes of Multidose Intravenous Azithromycin in Preterm Infants at Risk for Ureaplasma Respiratory Colonization

  2014cites this paper
• Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials.

  2014cites this paper
• Azithromycin: mechanisms of action and their relevance for clinical applications.

  2014cites this paper
• Intravenous Azithromycin in Preterm Infants at Risk for Ureaplasma Respiratory 2 Colonization 3 Running Title : Azithromycin 20 mg / kg multi-dose in preterm infants 4

  2014cites this paper